Evidence for functional selectivity in TUDC- and norUDCA-induced signal transduction via α


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
02 04 2020
Historique:
received: 26 07 2018
accepted: 02 03 2020
entrez: 4 4 2020
pubmed: 4 4 2020
medline: 25 11 2020
Statut: epublish

Résumé

Functional selectivity is the ligand-specific activation of certain signal transduction pathways at a receptor and has been described for G protein-coupled receptors. However, it has not yet been described for ligands interacting with integrins without αI domain. Here, we show by molecular dynamics simulations that four side chain-modified derivatives of tauroursodeoxycholic acid (TUDC), an agonist of α

Identifiants

pubmed: 32242141
doi: 10.1038/s41598-020-62326-y
pii: 10.1038/s41598-020-62326-y
pmc: PMC7118123
doi:

Substances chimiques

ATP Binding Cassette Transporter, Subfamily B, Member 11 0
Abcb11 protein, rat 0
Cholagogues and Choleretics 0
Integrin alpha5beta1 0
Taurochenodeoxycholic Acid 516-35-8
ursodoxicoltaurine 60EUX8MN5X
Ursodeoxycholic Acid 724L30Y2QR
ErbB Receptors EC 2.7.10.1
p38 Mitogen-Activated Protein Kinases EC 2.7.11.24

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5795

Références

Urban, J. D. et al. Functional selectivity and classical concepts of quantitative pharmacology. J. Pharmacol. Exp. Ther. 320, 1–13, https://doi.org/10.1124/jpet.106.104463 (2007).
doi: 10.1124/jpet.106.104463 pubmed: 16803859 pmcid: 16803859
Violin, J. D. & Lefkowitz, R. J. Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol. Sci. 28, 416–422, https://doi.org/10.1016/j.tips.2007.06.006 (2007).
doi: 10.1016/j.tips.2007.06.006 pubmed: 17644195 pmcid: 17644195
Simon, D. I. Opening the field of integrin biology to “biased agonism”. Circ. Res. 109, 1199–1201, https://doi.org/10.1161/CIRCRESAHA.111.257980 (2011).
doi: 10.1161/CIRCRESAHA.111.257980 pubmed: 22076504 pmcid: 22076504
Wolf, D. et al. Binding of CD40L to Mac-1’s I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis–but does not affect immunity and thrombosis in mice. Circ. Res. 109, 1269–1279, https://doi.org/10.1161/CIRCRESAHA.111.247684 (2011).
doi: 10.1161/CIRCRESAHA.111.247684 pubmed: 21998326 pmcid: 21998326
Gohlke, H., Schmitz, B., Sommerfeld, A., Reinehr, R. & Häussinger, D. α5β1-integrins are sensors for tauroursodeoxycholic acid in hepatocytes. Hepatology 57, 1117–1129, https://doi.org/10.1002/hep.25992 (2013).
doi: 10.1002/hep.25992 pubmed: 22865233 pmcid: 22865233
Volpes, R., van den Oord, J. J. & Desmet, V. J. Integrins as differential cell lineage markers of primary liver tumors. Am. J. Pathol. 142, 1483–1492 (1993).
pubmed: 7684197 pmcid: 7684197
Häussinger, D. et al. Involvement of Integrins and Src in Tauroursodeoxycholate-Induced and Swelling-Induced Choleresis. Gastroenterology 124, 1476–1487, https://doi.org/10.1016/S0016-5085(03)00274-9 (2003).
doi: 10.1016/S0016-5085(03)00274-9 pubmed: 12730886 pmcid: 12730886
Schliess, F., Reissmann, R., Reinehr, R., vom Dahl, S. & Häussinger, D. Involvement of Integrins and Src in Insulin Signaling toward Autophagic Proteolysis in Rat Liver. J. Biol. Chem. 279, 21294–21301, https://doi.org/10.1074/jbc.M313901200 (2004).
doi: 10.1074/jbc.M313901200 pubmed: 14985360 pmcid: 14985360
vom Dahl, S. et al. Involvement of Integrins in Osmosensing and Signaling toward Autophagic Proteolysis in Rat Liver. J. Biol. Chem. 278, 27088–27095, https://doi.org/10.1074/jbc.M210699200 (2003).
doi: 10.1074/jbc.M210699200 pubmed: 12721289 pmcid: 12721289
Kurz, A. K., Graf, D., Schmitt, M., vom Dahl, S. & Häussinger, D. Tauroursodesoxycholate-Induced Choleresis Involves p38(MAPK) Activation and Translocation of the Bile Salt Export Pump in Rats. Gastroenterology 121, 407–419, gast.2001.26262 (2001).
Schmitt, M., Kubitz, R., Lizun, S., Wettstein, M. & Häussinger, D. Regulation of the Dynamic Localization of the Rat Bsep Gene-Encoded Bile Salt Export Pump by Anisoosmolarity. Hepatology 33, 509–518, https://doi.org/10.1053/jhep.2001.22648 (2001).
doi: 10.1053/jhep.2001.22648
Hanke, J. H. et al. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 271, 695–701 (1996).
doi: 10.1074/jbc.271.2.695
Beuers, U. et al. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. Hepatology 33, 1206–1216, https://doi.org/10.1053/jhep.2001.24034 (2001).
doi: 10.1053/jhep.2001.24034
Kubitz, R., D’Urso, D., Keppler, D. & Häussinger, D. Osmodependent Dynamic Localization of the Multidrug Resistance Protein 2 in the Rat Hepatocyte Canalicular Membrane. Gastroenterology 113, 1438–1442, gast.1997.v113.pm9352844 (1997).
Cantore, M., Reinehr, R., Sommerfeld, A., Becker, M. & Häussinger, D. The Src Family Kinase Fyn Mediates Hyperosmolarity-Induced Mrp2 and Bsep Retrieval from Canalicular Membrane. J. Biol. Chem. 286, 45014–45029, https://doi.org/10.1074/jbc.M111.292896 (2011).
doi: 10.1074/jbc.M111.292896 pubmed: 3247936 pmcid: 3247936
Sommerfeld, A., Mayer, P. G. K., Cantore, M. & Häussinger, D. Regulation of Plasma Membrane Localization of the Na+-Taurocholate Cotransporting Polypeptide (Ntcp) by Hyperosmolarity and Tauroursodeoxycholate. J. Biol. Chem. 290, 24237–24254, https://doi.org/10.1074/jbc.M115.666883 (2015).
doi: 10.1074/jbc.M115.666883 pubmed: 4591811 pmcid: 4591811
Schliess, F., Kurz, A. K., vom Dahl, S. & Häussinger, D. Mitogen-Activated Protein Kinases Mediate the Stimulation of Bile Acid Secretion by Tauroursodeoxycholate in Rat Liver. Gastroenterology 113, 1306–1314, https://doi.org/10.1053/gast.1997.v113.pm9322526 (1997).
doi: 10.1053/gast.1997.v113.pm9322526
Stieger, B. Recent insights into the function and regulation of the bile salt export pump (ABCB11). Curr. Opin. Lipidol. 20, 176–181, https://doi.org/10.1097/MOL.0b013e32832b677c (2009).
doi: 10.1097/MOL.0b013e32832b677c
Bochen, A. et al. Biselectivity of isoDGR peptides for fibronectin binding integrin subtypes alpha5beta1 and alphavbeta6: conformational control through flanking amino acids. J. Med. Chem. 56, 1509–1519, https://doi.org/10.1021/jm301221x (2013).
doi: 10.1021/jm301221x
Mas-Moruno, C., Rechenmacher, F. & Kessler, H. Cilengitide: the first anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation. Anticancer Agents Med. Chem. 10, 753–768 (2010).
doi: 10.2174/187152010794728639
Zhu, J. et al. Structure of a Complete Integrin Ectodomain in a Physiologic Resting State and Activation and Deactivation by Applied Forces. Mol. Cell 32, 849–861, https://doi.org/10.1016/j.molcel.2008.11.018 (2008).
doi: 10.1016/j.molcel.2008.11.018 pubmed: 2758073 pmcid: 2758073
Van Agthoven, J. F. et al. Structural basis for pure antagonism of integrin αVβ3 by a high-affinity form of fibronectin. Nat. Struct. Mol. Biol. 21, 383–388, https://doi.org/10.1038/nsmb.2797 (2014).
doi: 10.1038/nsmb.2797 pubmed: 4012256 pmcid: 4012256
Zhu, J., Zhu, J. & Springer, T. A. Complete integrin headpiece opening in eight steps. J. Cell Biol. 201, 1053–1068, https://doi.org/10.1083/jcb.201212037 (2013).
doi: 10.1083/jcb.201212037 pubmed: 3691460 pmcid: 3691460
Puklin-Faucher, E. & Vogel, V. Integrin activation dynamics between the RGD-binding site and the headpiece hinge. J. Biol. Chem. 284, 36557–36568, https://doi.org/10.1074/jbc.M109.041194 (2009).
doi: 10.1074/jbc.M109.041194 pubmed: 2794771 pmcid: 2794771
Puklin-Faucher, E., Gao, M., Schulten, K. & Vogel, V. How the headpiece hinge angle is opened: New insights into the dynamics of integrin activation. J. Cell Biol. 175, 349–360, https://doi.org/10.1083/jcb.200602071 (2006).
doi: 10.1083/jcb.200602071 pubmed: 2064575 pmcid: 2064575
Puklin-Faucher, E. & Sheetz, M. P. The mechanical integrin cycle. J. Cell Sci. 122, 179–186, https://doi.org/10.1242/jcs.042127 (2009).
doi: 10.1242/jcs.042127
Craig, D., Gao, M., Schulten, K. & Vogel, V. Structural insights into how the MIDAS ion stabilizes integrin binding to an RGD peptide under force. Structure 12, 2049–2058, https://doi.org/10.1016/j.str.2004.09.009 (2004).
doi: 10.1016/j.str.2004.09.009
Nakazawa, T., Hoshino, M., Hayakawa, T., Tanaka, A. & Ohiwa, T. Vasopressin reduces taurochenodeoxycholate-induced hepatotoxicity by lowering the hepatocyte taurochenodeoxycholate content. J. Hepatol. 25, 739–747, https://doi.org/10.1016/s0168-8278(96)80247-9 (1996).
doi: 10.1016/s0168-8278(96)80247-9
Agellon, L. B. & Torchia, E. C. Intracellular transport of bile acids. Biochim. Biophys. Acta 1486, 198–209, https://doi.org/10.1016/s1388-1981(00)00057-3 (2000).
doi: 10.1016/s1388-1981(00)00057-3
Setchell, K. D. et al. Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei. Gastroenterology 112, 226–235, https://doi.org/10.1016/s0016-5085(97)70239-7 (1997).
doi: 10.1016/s0016-5085(97)70239-7 pubmed: 8978363 pmcid: 8978363
vom Dahl, S., Hallbrucker, C., Lang, F. & Häussinger, D. Regulation of cell volume in the perfused rat liver by hormones. Biochem. J. 280(Pt 1), 105–109 (1991).
doi: 10.1042/bj2800105
König, J., Klatt, S., Dilger, K. & Fromm, M. F. Characterization of Ursodeoxycholic and Norursodeoxycholic Acid as Substrates of the Hepatic Uptake Transporters OATP1B1, OATP1B3, OATP2B1 and NTCP. Basic Clin. Pharmacol. Toxicol. 111, 81–86, https://doi.org/10.1111/j.1742-7843.2012.00865.x (2012).
doi: 10.1111/j.1742-7843.2012.00865.x
Ko, J. et al. Effects of side chain length on ionization behavior and transbilayer transport of unconjugated dihydroxy bile acids: a comparison of nor-chenodeoxycholic acid and chenodeoxycholic acid. J. Lipid Res. 35, 883–892 (1994).
pubmed: 8071610 pmcid: 8071610
Jedlitschky, G. et al. ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. Biochem. J. 327(Pt 1), 305–310 (1997).
doi: 10.1042/bj3270305
Kamisako, T. et al. Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant human and rat multidrug resistance protein 2. Hepatology 30, 485–490, https://doi.org/10.1002/hep.510300220 (1999).
doi: 10.1002/hep.510300220
Cui, Y. et al. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol. Pharmacol. 55, 929–937 (1999).
Denk, G. U. et al. Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver. Hepatology 52, 1758–1768, https://doi.org/10.1002/hep.23911 (2010).
doi: 10.1002/hep.23911
Norris, R. P., Freudzon, M., Nikolaev, V. O. & Jaffe, L. A. Epidermal growth factor receptor kinase activity is required for gap junction closure and for part of the decrease in ovarian follicle cGMP in response to LH. Reproduction 140, 655–662, https://doi.org/10.1530/REP-10-0288 (2010).
doi: 10.1530/REP-10-0288 pubmed: 3119707 pmcid: 3119707
Rubio, I. et al. Ras activation in response to phorbol ester proceeds independently of the EGFR via an unconventional nucleotide-exchange factor system in COS-7 cells. Biochem. J 398, 243–256, https://doi.org/10.1042/BJ20060160 (2006).
doi: 10.1042/BJ20060160 pubmed: 1550314 pmcid: 1550314
Berger, C., Krengel, U., Stang, E., Moreno, E. & Madshus, I. H. Nimotuzumab and cetuximab block ligand-independent EGF receptor signaling efficiently at different concentrations. J. Immunother. 34, 550–555, https://doi.org/10.1097/CJI.0b013e31822a5ca6 (2011).
doi: 10.1097/CJI.0b013e31822a5ca6
Hofmann, A. F. et al. Novel biotransformation and physiological properties of norursodeoxycholic acid in humans. Hepatology 42, 1391–1398, https://doi.org/10.1002/hep.20943 (2005).
doi: 10.1002/hep.20943
Trauner, M. et al. Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic Disorders. Dig. Dis. 33, 433–439, https://doi.org/10.1159/000371904 (2015).
doi: 10.1159/000371904
Kurz, A. K. et al. Phosphoinositide 3-kinase-dependent Ras activation by tauroursodesoxycholate in rat liver. Biochem. J. 350(Pt 1), 207–213, https://doi.org/10.1042/bj3500207 (2000).
doi: 10.1042/bj3500207 pubmed: 1221243 pmcid: 1221243
Kim, N.-G. & Gumbiner, B. M. Adhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway. J. Cell Biol. 210, 503–515, https://doi.org/10.1083/jcb.201501025 (2015).
doi: 10.1083/jcb.201501025 pubmed: 4523609 pmcid: 4523609
Sampaio, C. et al. Signal Strength Dictates Phosphoinositide 3-Kinase Contribution to Ras/Extracellular Signal-Regulated Kinase 1 and 2 Activation via Differential Gab1/Shp2 Recruitment: Consequences for Resistance to Epidermal Growth Factor Receptor Inhibition. Mol. Cell. Biol. 28, 587–600, https://doi.org/10.1128/MCB.01318-07 (2008).
doi: 10.1128/MCB.01318-07
Clark, E. A. & Brugge, J. S. Integrins and signal transduction pathways: the road taken. Science 268, 233–239, https://doi.org/10.1126/science.7716514 (1995).
doi: 10.1126/science.7716514
García, A. J. & Boettiger, D. Integrin-fibronectin interactions at the cell-material interface: initial integrin binding and signaling. Biomaterials 20, 2427–2433, https://doi.org/10.1016/S0142-9612(99)00170-2 (1999).
doi: 10.1016/S0142-9612(99)00170-2
Mitra, S. K., Hanson, D. A. & Schlaepfer, D. D. Focal adhesion kinase: in command and control of cell motility. Nature Reviews Molecular Cell Biology 6, 56–68, https://doi.org/10.1038/nrm1549 (2005).
doi: 10.1038/nrm1549
Huveneers, S. & Danen, E. H. J. Adhesion signaling - crosstalk between integrins, Src and Rho. J. Cell Sci. 122, 1059–1069, https://doi.org/10.1242/jcs.039446 (2009).
doi: 10.1242/jcs.039446 pubmed: 19339545 pmcid: 19339545
Shah, B. H., Neithardt, A., Chu, D. B., Shah, F. B. & Catt, K. J. Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs. J. Cell. Physiol. 206, 47–57, https://doi.org/10.1002/jcp.20423 (2006).
doi: 10.1002/jcp.20423
Yoon, Y. B. et al. Effect of side-chain shortening on the physiologic properties of bile acids: hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents. Gastroenterology 90, 837–852 (1986).
doi: 10.1016/0016-5085(86)90859-0
Fickert, P. et al. 24-norUrsodeoxycholic Acid is Superior to Ursodeoxycholic Acid in the Treatment of Sclerosing Cholangitis in Mdr2 (Abcb4) Knockout Mice. Gastroenterology 130, 465–481, https://doi.org/10.1053/j.gastro.2005.10.018 (2006).
doi: 10.1053/j.gastro.2005.10.018
Noe, J., Stieger, B. & Meier, P. J. Functional expression of the canalicular bile salt export pump of human liver. Gastroenterology 123, 1659–1666, https://doi.org/10.1053/gast.2002.36587 (2002).
doi: 10.1053/gast.2002.36587
Stieger, B. et al. In situ localization of the hepatocytic Na+/Taurocholate cotransporting polypeptide in rat liver. Gastroenterology 107, 1781–1787, https://doi.org/10.1016/0016-5085(94)90821-4 (1994).
doi: 10.1016/0016-5085(94)90821-4
Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graphics 14(33-38), 27–38, https://doi.org/10.1016/0263-7855(96)00018-5 (1996).
doi: 10.1016/0263-7855(96)00018-5
Xiao, T., Takagi, J., Coller, B. S., Wang, J.-H. & Springer, T. A. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 432, 59–67, https://doi.org/10.1038/nature02976 (2004).
doi: 10.1038/nature02976 pubmed: 4372090 pmcid: 4372090
Roe, D. R. & Cheatham, T. E. III. PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. J. Chem. Theory Comput. 9, 3084–3095, https://doi.org/10.1021/ct400341p (2013).
doi: 10.1021/ct400341p
Sies, H. The use of perfusion of liver and other organs for the study of microsomal electron-transport and cytochrome P-450 systems. Methods Enzymol. 52, 48–59, https://doi.org/10.1016/S0076-6879(78)52005-3 (1978).
doi: 10.1016/S0076-6879(78)52005-3
R: A language and environment for statistical computing (R Foundation for Statistical Computing, Vienna, Austria, 2010).

Auteurs

Michele Bonus (M)

Institute for Pharmaceutical and Medicinal Chemistry, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Annika Sommerfeld (A)

Clinic for Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Natalia Qvartskhava (N)

Clinic for Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Boris Görg (B)

Clinic for Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Beatrice Stefanie Ludwig (BS)

Institute for Advanced Study and Center for Integrated Protein Science, Department of Chemistry, Technische Universität München, Garching, Germany.

Horst Kessler (H)

Institute for Advanced Study and Center for Integrated Protein Science, Department of Chemistry, Technische Universität München, Garching, Germany.

Holger Gohlke (H)

Institute for Pharmaceutical and Medicinal Chemistry, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. gohlke@uni-duesseldorf.de.
John von Neumann Institute for Computing (NIC), Jülich Supercomputing Centre (JSC), and Institute for Complex Systems - Structural Biochemistry (ICS-6), Forschungszentrum Jülich GmbH, Jülich, Germany. gohlke@uni-duesseldorf.de.

Dieter Häussinger (D)

Clinic for Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. haeussin@uni-duesseldorf.de.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH